Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma. [PDF]
Li L +7 more
europepmc +1 more source
Termination of Pregnancy in a Patient with Advanced Ovarian Cancer
Ovarian cancer during pregnancy is a rare entity and the management of the disease can be challenging for the patient and the clinician. In this case, we report a case of advanced ovarian carcinoma diagnosed during pregnancy, which was managed with ...
Suna Özdemir +3 more
doaj
Social, Genetics and Histopathological Factors Related to Titin (TTN) Gene Mutation and Survival in Women with Ovarian Serous Cystadenocarcinoma: Bioinformatics Analysis. [PDF]
Gomes FC +13 more
europepmc +1 more source
TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets. [PDF]
Zhang C +7 more
europepmc +1 more source
ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis. [PDF]
Zhang Y, Du T, Chen X.
europepmc +1 more source
Background: Ovarian cancer is a significant global health concern, ranking 5th among cancer deaths among women and causing more deaths than any other cancer of the female reproductive system.
Priya R +2 more
doaj +1 more source
OBJECTIVES: Adipokines are currently the subject of numerous intensive studies due to their multidirectional effects in the formation and development of many cancers, including ovarian cancer.
Sebastian Stepien +5 more
doaj +1 more source
Gene Expression Subtyping Reveals Immune alterations:TCGA Database for Prognosis in Ovarian Serous Cystadenocarcinoma. [PDF]
Feng C +11 more
europepmc +1 more source
Background: Cancers in adolescents and young adults (AYA) represents a bridge between childhood and elderly incidence curves of cancers demanding tailored approaches and management of their distinct presentations.
Parul Singh +6 more
doaj +1 more source
A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma. [PDF]
Yu Z, He H, Chen Y, Ji Q, Sun M.
europepmc +1 more source

